Source:http://linkedlifedata.com/resource/pubmed/id/20812906
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
1
|
pubmed:dateCreated |
2011-3-11
|
pubmed:abstractText |
In the etiology of brain injury associated to ischemia/reperfusion (I/R) and neurodegenerative diseases, a critical involvement of excessive activation of signal transducer and activator of transcription 1 (STAT1) and successive induction of iNOS expression has widely been evidenced. Any compound capable to down-regulate STAT1 activation seems to represent a new, promising anti-inflammatory drug. Among plant compounds, only a few have shown to possess anti-STAT1 activity. Among them, epigallocatechin-3-gallate (EGCG), the main polyphenol present in green tea leaves, efficiently protects heart from I/R injury and this action is strictly correlated to its anti-STAT1 property. Hyperforin, the non-polyphenolic compound present in St. John's wort, attenuates β-cell death induced by interferon-γ (IFN-γ) by strongly down-regulating STAT1 activation. STAT1, therefore, seems to represent a new molecular target of the protective treatment also against brain injury associated to a number of brain pathologies. Either understanding the molecular mechanism of anti-STAT1 action of these compounds or identification of other anti-STAT1 compounds are urged.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Bicyclo Compounds,
http://linkedlifedata.com/resource/pubmed/chemical/Catechin,
http://linkedlifedata.com/resource/pubmed/chemical/Janus Kinases,
http://linkedlifedata.com/resource/pubmed/chemical/Neuroprotective Agents,
http://linkedlifedata.com/resource/pubmed/chemical/Phloroglucinol,
http://linkedlifedata.com/resource/pubmed/chemical/STAT1 Transcription Factor,
http://linkedlifedata.com/resource/pubmed/chemical/Terpenes,
http://linkedlifedata.com/resource/pubmed/chemical/epigallocatechin gallate,
http://linkedlifedata.com/resource/pubmed/chemical/hyperforin
|
pubmed:status |
MEDLINE
|
pubmed:month |
Mar
|
pubmed:issn |
1875-6166
|
pubmed:author | |
pubmed:issnType |
Electronic
|
pubmed:day |
1
|
pubmed:volume |
11
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
2-7
|
pubmed:meshHeading |
pubmed-meshheading:20812906-Animals,
pubmed-meshheading:20812906-Bicyclo Compounds,
pubmed-meshheading:20812906-Brain,
pubmed-meshheading:20812906-Catechin,
pubmed-meshheading:20812906-Humans,
pubmed-meshheading:20812906-Janus Kinases,
pubmed-meshheading:20812906-Molecular Structure,
pubmed-meshheading:20812906-Neurodegenerative Diseases,
pubmed-meshheading:20812906-Neuroprotective Agents,
pubmed-meshheading:20812906-Phloroglucinol,
pubmed-meshheading:20812906-Reperfusion Injury,
pubmed-meshheading:20812906-STAT1 Transcription Factor,
pubmed-meshheading:20812906-Signal Transduction,
pubmed-meshheading:20812906-Terpenes
|
pubmed:year |
2011
|
pubmed:articleTitle |
Use of STAT1 inhibitors in the treatment of brain I/R injury and neurodegenerative diseases.
|
pubmed:affiliation |
Dipartimento di Scienze Morfologico-Biomediche, Università di Verona, Verona, Italy.
|
pubmed:publicationType |
Journal Article,
Review
|